Arthritis
Repair of posterior meniscal root tears delayed time to knee arthroplasty
Results of a matched cohort comparison of 45 patients with medial meniscal root tears who underwent either nonsurgical management, partial meniscectomy or repair showed significant differences among the groups for progression to knee arthroplasty, with the meniscus root repair group having significantly less arthritic progression based on changes in Kellgren-Lawrence grade.
Bone graft substitute for tunnel filling improved ACL reconstruction outcomes
Infliximab biosimilars 'more rapidly incorporated' in VA vs. academic centers
‘Worrisome’ rise in autoimmunity reported in U.S.
The prevalence of antinuclear antibodies, markers of the body’s immune responses against its own cells, has increased significantly in the United States over the past several decades, particularly among adolescents and adults aged 50 years and older, according to data published in Arthritis & Rheumatology.
AAOS, Orthopaedic Research and Education Foundation recognize work of Braden C. Fleming, PhD
The American Academy of Orthopaedic Surgeons announced Braden C. Fleming, PhD, received the Orthopaedic Research and Education Foundation Clinical Research Award for more than 15 years of clinical research conducted with his colleagues into certain mechanical, psychological and biological factors that may lead to the onset and progression of post-traumatic osteoarthritis following ACL reconstruction.
FDA approves wrist replacement implant designed by HSS surgeon
High volume of irrigation may reduce risk of recurrent septic arthritis of the shoulder
Onsite With Orlando Health Arnold Palmer Hospital for Children: Pediatric rheumatology care built from scratch
With more than 300,000 children with arthritis and other rheumatic conditions across the United States, and fewer than 350 pediatric rheumatologists to treat them, Monica L. Friedman, DO, of Orlando Health Arnold Palmer Hospital for Children, is on the front lines of the growing rheumatology shortage.
CDC: Nearly a third of US adults with arthritis also has history of depression
Therapeutic Drug Monitoring Not Ready for Prime Time in Rheumatology
Common sense might dictate that, in maintaining health and wellness, being proactive is generally better than being reactive. But the practice of medicine often demands more than just common sense — it demands data and evidence to support clinical decision making. The discussion of therapeutic drug monitoring for biologic therapies hinges on this conundrum. Proactive monitoring appears to be the common-sense approach, but the data supporting its use have not yet closed the case.